SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-015005
Filing Date
2017-06-01
Accepted
2017-06-01 17:22:43
Documents
2
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2181
2 EX-24 DOCUMENT attachment1.htm EX-24 4588
  Complete submission text file 0000899243-17-015005.txt   8117
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS, INC. 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
KASINGER JAMES R. (Reporting) CIK: 0001708172 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 17885729